最新国产精品V在线播放观看不卡,久久AV国产麻豆HD真实乱,成人网站国产99,成人国产精品探花在线观看,国产乱子经典视频在线观看

心型脂肪酸結(jié)合蛋白(H-FABP)活性蛋白

Active Heart-type Fatty Acid Binding Protein (H-FABP)

MDGI; FABP11; H-FABP; O-FABP; Hfabp; FABP3; Fatty Acid Binding Protein 3, Muscle And Heart; Mammary Derived Growth Inhibitor; Fatty Acid Binding Protein 11; Muscle fatty acid-binding protein; Heart-ty

  • 心型脂肪酸結(jié)合蛋白(H-FABP)活性蛋白 產(chǎn)品包裝(模擬)
  • 心型脂肪酸結(jié)合蛋白(H-FABP)活性蛋白 產(chǎn)品包裝(模擬)
  • 心型脂肪酸結(jié)合蛋白(H-FABP)活性蛋白 Figure. Gene Sequencing (extract)
  • APB243Hu01.png Figure. SDS-PAGE
  • 心型脂肪酸結(jié)合蛋白(H-FABP)活性蛋白 Figure. Western Blot
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

活性實(shí)驗(yàn)

Fatty Acid Binding Protein 3, Muscle And Heart (FABP3) also known as mammary-derived growth inhibitor is a protein that in humans is encoded by the FABP3 gene. FABP3 is a small cytoplasmic protein (15kDa) released from cardiac myocytes following an ischemic episode. It is involved in active fatty acid metabolism where it transports fatty acids from the cell membrane to mitochondria for oxidation. Besides, Fatty Acid Binding Protein 3, Muscle And Heart (FABP3) has been identified as an interactor of SOD1, thus a binding ELISA assay was conducted to detect the interaction of recombinant human FABP3 and recombinant human SOD1. Briefly, FABP3 were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100μL were then transferred to SOD1-coated microtiter wells and incubated for 2h at 37℃. Wells were washed with PBST and incubated for 1h with anti-FABP3 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50μL stop solution to the wells and read at 450nm immediately. The binding activity of FABP3 and SOD1 was shown in Figure 1, and this effect was in a dose dependent manner.
Figure. The binding activity of FABP3 with SOD1.

用法

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

儲(chǔ)存

避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。

相關(guān)產(chǎn)品

編號(hào) 適用物種:Homo sapiens (Human,人) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
URPB243Hu01 心型脂肪酸結(jié)合蛋白(H-FABP)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UAPB243Hu01 心型脂肪酸結(jié)合蛋白(H-FABP)活性蛋白 Cell?culture;?Activity?Assays.
UEPB243Hu61 心型脂肪酸結(jié)合蛋白(H-FABP)真核蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UPAB243Hu01 心型脂肪酸結(jié)合蛋白(H-FABP)多克隆抗體 WB; IHC; ICC/IF; FCM
ULAB243Hu81 心型脂肪酸結(jié)合蛋白(H-FABP)多克隆抗體(異硫氰酸熒光素標(biāo)記) WB; IHC; ICC; IF.
ULAB243Hu71 心型脂肪酸結(jié)合蛋白(H-FABP)多克隆抗體(生物素標(biāo)記) WB; IHC; ICC.
UMAB243Hu26 心型脂肪酸結(jié)合蛋白(H-FABP)單克隆抗體 WB
UMAB243Hu23 心型脂肪酸結(jié)合蛋白(H-FABP)單克隆抗體 WB
UMAB243Hu24 心型脂肪酸結(jié)合蛋白(H-FABP)單克隆抗體 WB
UMAB243Hu25 心型脂肪酸結(jié)合蛋白(H-FABP)單克隆抗體 IHC
UMAB243Hu27 心型脂肪酸結(jié)合蛋白(H-FABP)單克隆抗體 IHC
UMAB243Hu21 心型脂肪酸結(jié)合蛋白(H-FABP)單克隆抗體 WB; IHC; ICC/IF
UMAB243Hu22 心型脂肪酸結(jié)合蛋白(H-FABP)單克隆抗體 WB; IHC; ICC/IF
UMAB243Hu29 心型脂肪酸結(jié)合蛋白(H-FABP)單克隆抗體 WB
UFAB243Hu02 抗心型脂肪酸結(jié)合蛋白(H-FABP)單克隆抗體 FCM
ULAB243Hu72 心型脂肪酸結(jié)合蛋白(H-FABP)單克隆抗體(生物素標(biāo)記) WB
ULAB243Hu82 心型脂肪酸結(jié)合蛋白(H-FABP)單克隆抗體(異硫氰酸熒光素標(biāo)記) WB; IHC; ICC; IF.
UHEB243Hu 心型脂肪酸結(jié)合蛋白(H-FABP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型) Enzyme-linked immunosorbent assay for Antigen Detection.
USEB243Hu 心型脂肪酸結(jié)合蛋白(H-FABP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) Enzyme-linked immunosorbent assay for Antigen Detection.
ULMB243Hu 心型脂肪酸結(jié)合蛋白(H-FABP)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.
UKSB243Hu01 心型脂肪酸結(jié)合蛋白(H-FABP)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) 自己動(dòng)手制作ELISA試劑盒的主要材料

參考文獻(xiàn)

雜志 參考文獻(xiàn)
Molecular Medicine Reports Protective effects of N (2)?L?alanyl?L?glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion [Pubmed:29393473]
Oncology?Letters Hydrogen?rich solution attenuates myocardial injury caused by cardiopulmonary bypass in rats via the Janus?activated kinase 2/signal transducer and activator of?… [Pubmed:29928398]
FASEB?Journal Signature-oriented investigation of the efficacy of multicomponent drugs against heart failure [Pubmed: 30230922]
留言咨詢